Compare CRL & MSGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRL | MSGS |
|---|---|---|
| Founded | 1947 | 1879 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 8.2B |
| IPO Year | 1999 | 2015 |
| Metric | CRL | MSGS |
|---|---|---|
| Price | $167.20 | $327.39 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $198.27 | ★ $341.29 |
| AVG Volume (30 Days) | ★ 727.5K | 178.6K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,857,601,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.04 | $4.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 10.48 | N/A |
| 52 Week Low | $114.24 | $184.63 |
| 52 Week High | $228.88 | $345.48 |
| Indicator | CRL | MSGS |
|---|---|---|
| Relative Strength Index (RSI) | 43.79 | 51.98 |
| Support Level | $166.86 | $303.92 |
| Resistance Level | $182.76 | $335.08 |
| Average True Range (ATR) | 6.51 | 8.39 |
| MACD | -1.29 | -0.74 |
| Stochastic Oscillator | 6.71 | 38.10 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Madison Square Garden Sports Corp owns and operates a portfolio of assets featuring some of the recognized sports teams, including the Knicks of the NBA and the Rangers of the NHL. It generates revenue from several sources: ticket sales and a portion of suite rental fees at The Garden and others. It has one operating and reportable segment and one reporting unit for goodwill impairment testing purposes.